—
Since 9/11/2001, this country has fought two major wars with, combined, almost 30 years of combat operations involving hundreds of thousands of American men and women. And yet it’s been 25 years — going all the way back to 1999 — since the last time members of a Food and Drug Administration advisory panel even bothered to discuss permitting research into new treatments for Post-Traumatic Stress Disorder (PTSD).
Ourvetswillhavetowaitevenlonger,itseems,butI’llgettothatmomentarily.
TheNewYorkTimesreportedTuesdaythat“RoughlysixpercentoftheAmericanpopulationwilldevelopPTSDatsomepointintheirlives.Onlyafractionofthosepatientscurrentlyrecover.”That’saccordingtotheFDA’sDr.TiffanyR.Farchione.
LastmonthIwroteacolumnforourVIPsupportersdetailingaLykosTherapeuticsrequestforFDApermissiontostudyMDMA-assistedtherapyforpeoplesufferingfrompost-traumaticstressdisorder(PTSD),mostlyveterans.MDMAistheillegalpsychedelicdrugcommonlyknownasecstasyormolly.
WhileMDMAisnotacure-allforPTSD,multiplesmallstudieshaveshownthatthewayitwor
